1. |
Zbuk K, Anand SS. Declining incidence of breast cacner after decreased use of hormone-replacement therapy:magnitude and time lags in different countries. J Epidemiol Community Health, 2012, 66(1):1-7.
|
2. |
张敏璐, 黄哲宙, 郑莹.中国年女性乳腺癌发病、死亡和患病情况的估计及预测.中华流行病学杂志, 2012, 33(10):1049-1051.
|
3. |
赵艳杰, 王睿斌, 宋光雨, 等.乳腺癌与甲状腺疾病相关性的临床研究.肿瘤研究与临床, 2013, 25(3):178-180.
|
4. |
杨纾旖, 地力木拉提·艾斯木吐拉, 王永高, 等.甲状腺特异性抗体与乳腺癌相关性研究的系统评价.现代生物医学进展, 2014, 14(6):1170-1173.
|
5. |
Ergür AT, Taner Y, Ata E, et al. Neurocognitive functions in children and adolescents with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol, 2012, 4(1):21-24.
|
6. |
吴万敏, 张艳.乳腺癌中THRβ1表达与甲状腺激素改变的临床研究.临床和实验医学杂志, 2014, 13(18):1513-1517.
|
7. |
Ryan J, Curran CE, Hennessy E, et al. The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One, 2011, 6(1):e16023.
|
8. |
Kilbane MT, Ajjan RA, Weetman AP, et al. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab, 2000, 85(3):1245-1250.
|
9. |
马科航, 杨亮.甲状腺疾病患者血清三碘甲腺原氨酸、甲状腺素和促甲状腺素的检测分析.现代诊断与治疗, 2014, 25(8):1872-1873.
|
10. |
Gärtner R, Rank P, Ander B. The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones (A thens), 2010, 9(1):60-66.
|
11. |
Huang J, Jin L, Ji G, et al. Implication from thyroid funciation decreasing during chemotherapy in breast cancer patients:chemosensitization role of triiodothyroine. BMC Cancer, 2013, 13:334.
|
12. |
Ni Y, He X, Chen J, et al. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet, 2012, 21(2):300-310.
|
13. |
Tosovic A, Becker C, Bondeson AG, et al. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer, 2012, 131(9):2126-2133.
|
14. |
Sar P, Peter R, Rath B, et al. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. PLoS One, 2011, 6(6):e20861.
|
15. |
Dinda S, Sanchez A, Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene, 2002, 21(5):761-768.
|
16. |
Conde SJ, Luvizotto Rde A, de Síbio MT, et al. Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women. ISRN Endocrinol, 2014, 2014:317398.
|
17. |
Tosovic A, Bondeson AG, Bondeson L, et al. Prospectively measured triiodothyronine levels are positively associated with breast caJlcer risk in postmenopausal women. Breast Cancer Res, 2010, 12(3):R33.
|
18. |
夏敏玲, 陈思佳.乳腺癌患者血清甲状腺激素水平检测及其临床意义.中国病案, 2011, 12(10):68-69.
|
19. |
高莹, 李秀珍, 张玥, 等.低T3综合征与危重症.中华全科医学, 2013, 11(12):1858-1859.
|
20. |
Kuijpens JL, Nyklíctek I, Louwman MW, et al. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid, 2005, 15(11):1253-1259.
|
21. |
Gogas J, Kouskos E, Tseleni-Balafouta S, et al. Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol, 2001, 27(7):626-630.
|
22. |
Smyth PP. Autoimmune thyroid disease and breast cancer:a chance association. Endocrinol Invest, 2000, 23(1):42-43.
|
23. |
Hsu SF, Goan YG, Tsai HY, et al. An upstream regulatory element confers orientation independent enhancement of the TSG101 promoter activity in transformed cells. Mol Biol Rep, 2012, 39(1):517-525.
|
24. |
Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Res, 2003, 5(5):235-238.
|
25. |
Eskes SA, Endert E, Fliers E, et al. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol, 2014, 80(3):444-451.
|
26. |
Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol, 2004, 150(5):605-618.
|
27. |
Tosovic A, Becker C, Bondeson AG, et al. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer, 2012, 131(19):2126-2133.
|
28. |
Prinzi N, Baldini E, Sorrenti S, et al. Prevalence of breast cancer in thyroid diseases:results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat, 2014, 144(3):683-688.
|